Malaysian Genomics Resource (0155) — Cash Flow Quality Index

Latest as of June 2026: 1.53x

Malaysian Genomics Resource (0155) has a Cash Flow Quality Index of 1.53x as of June 2026. Operating cash flow of RM1.01 Million exceeds net income of RM660.00K, indicating high earnings quality where cash backs reported profits. Explore 0155 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

1.53x
Operating CF / Net Income

Operating Cash Flow

RM1.01 Million
MYR

Net Income

RM660.00K
MYR

Data as of

Jun 2026
Most recent filing

Malaysian Genomics Resource Cash Flow Quality Index (2015–2022)

Historical Cash Flow Quality Index for Malaysian Genomics Resource across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Malaysian Genomics Resource.

Annual Cash Flow Quality Index for Malaysian Genomics Resource (2015–2022)

Year-by-year earnings quality comparison for Malaysian Genomics Resource.

Year Quality Index Operating CF (MYR) Net Income YoY Change
2022 0.01x RM56.92K RM7.21 Million ▼ -98.8%
2020 0.68x RM11.67 Million RM17.10 Million ▼ -87.6%
2017 5.50x RM3.67 Million RM668.26K ▲ +160.8%
2016 2.11x RM3.68 Million RM1.75 Million ▲ +1833.3%
2015 0.11x RM395.83K RM3.63 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.